Droxinostat (NS 41080)

Name: Droxinostat (NS 41080); MyBioSource
Brand: MyBioSource
SKU: MBS3606912
Price: 215 USD
Availability: InStock
Rating: 5 (10 reviews)

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS3606912

Droxinostat (NS-41080) is a selective HDAC inhibitor with IC50 of 16.9, 2.47 and 1.46 uM for HDAC3, HDAC6 and HDAC8, respectively. More details

$215 / 1mL*10mM (in DMSO) +1 FREE 8GB USB

Product Documentation

Sample Manual Insert View PDF

Testing Data View PDF

Certificate of Analysis (COA) View PDF

QC Report View PDF

Material Safety Data Sheet View PDF

Technical Datasheet View PDF

Protocol View PDF

Product Overview

Online Datasheet in PDF

Product Name

Droxinostat, Biochemical

Full Product Name

Droxinostat

Product Synonym Names

NS 41080; NS-41080; NS41080

Purity/Purification

>98% (HPLC)

Preparation and Storage

Store at -20 degree C
Stability: >=2 years
Shipping: Ice Pack

Molecular Weight

243.7

Suitability

10mM in DMSO

Target

HDAC

Receptor

HDAC10; HDAC3; HDAC6; HDAC8; HDAC9

Chemical Name

Butanamide, 4-(4-chloro-2-methylphenoxy)-N-hydroxy

SMILES

O=C(NO)CCCOC1=CC=C(Cl)C=C1C

Molecular Formula

C11H14ClNO3

CAS Number

99873-43-5

Product Categories/Family for Droxinostat biochemical

Cell Cycle/DNA Damage; Cancer

Product References and Citations for Droxinostat biochemical

1. Wood TE, et al. Mol Cancer Ther. 2010 Jan; 9 (1):246-56.
2. Bijangi-Vishehsaraei K, et al. Mol Cell Biochem. 2010 Sep; 342 (1-2):133-142.
3. McCourt C, et al. Clin Cancer Res. 2012 Jul 15; 18 (14):3822-33.
4. Liu J, et al. Transl Oncol. 2016 Feb; 9 (1):70-78.

Other Notes

Small volumes of Droxinostat biochemical vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Droxinostat purchase

MBS3606912 is a biochemical targeting Droxinostat.